Crystal P: AI Is Not Replacing Human Expertise, It’s Expanding It
Crystal P, Senior Manager, U.S. Regulatory Policy at Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”I had the privilege of moderating yesterday’s panel, “AI in Our Industry,” at the Plasma Protein Therapeutics Association (PPTA) annual conference.
The conversation brought together some of the most forward-thinking voices shaping how technology intersects with plasma-derived therapies.
Jan Hartmann shared how AI-driven insights and real-world data are redefining donor safety and efficiency.
Thomas Szatkowski highlighted how data infrastructure and digital transformation can unlock agility across the plasma supply chain.
Valerie J. Parker offered a policy lens on building governance frameworks that foster innovation responsibly, and Dr. Vic Boddie II grounded our discussion in the importance of maintaining the human element in AI oversight and decision-making.
The throughline was clear: AI is not replacing human expertise. It’s expanding it.
And as our industry evolves, collaboration between regulators, academia, and policymakers will be essential to ensure these technologies enhance quality, trust, and operation efficiencies!
Thank you to each panelist for your candor and insight, and to everyone who joined us for such an engaging discussion!”
Stay updated with Hemostasis Today.
-
Mar 7, 2026, 16:24Kalpana Gupta Shekhawat: The Overlooked Regulator of Mast Cells – Understanding the Vagus Nerve
-
Mar 7, 2026, 16:20Purusotham Chippala: How DALYs Reveal the True Burden of Stroke
-
Mar 7, 2026, 16:13Ilenia Calcaterra: Patient-Level Real-World Outcomes of Emicizumab in Acquired Hemophilia A
-
Mar 7, 2026, 16:05Iyas Daghlas: DOACs Use, Genetic Reduction of Coagulation Factors and Risk of Cerebral Venous Thrombosis
-
Mar 7, 2026, 15:58Aurelio Maggio: The Mission and The Projects We Are Advancing for Rare Hematologic Diseases
-
Mar 7, 2026, 15:52Faizan Khan: The Importance of Cancer Site in Bleeding Risk Stratification for Cancer-Associated VTE
-
Mar 7, 2026, 15:50Heghine Khachatryan: How DOACs Can Cause False-Positive FVIII Inhibitor Results
-
Mar 7, 2026, 15:43Gevorg Tamamyan Joins The London Global Cancer Week Steering Group
-
Mar 7, 2026, 15:36Kenneth Monaghan: Empowering Stroke Survivors’ Self-Efficacy Through Neuroplasticity and Daily Activity